The DIAPH3 Knockout HeLa Polyclonal Cells product comprises a polyclonal population of HeLa cells in which the DIAPH3 gene has been disrupted via CRISPR/Cas9 gene editing. This heterogeneous cell pool carries diverse edit alleles, collectively eliminating functional DIAPH3 protein. The use of polyclonal knockout cells provides a cost-effective loss-of-function model that circumvents clonal isolation, offering a robust platform for studying bulk cellular phenotypes. The CRISPR/Cas9 system introduces targeted double-strand breaks, leading to gene disruption through endogenous repair pathways.
HeLa cells are an immortalized epithelial line derived from a human cervical adenocarcinoma, widely used as a model for cancer cell biology. They exhibit rapid proliferation, robust actin cytoskeletal dynamics, and responsiveness to Rho GTPase signals, making them ideal for studying cell migration and invasion. Extensive characterization and genomic resources for HeLa cells facilitate data integration and comparison with published studies. Their epithelial origin directly complements investigations into actin-driven mesenchymal and amoeboid motility modes relevant to metastasis. Wild-type HeLa cells actively extend lamellipodia and filopodia, which depend on formin-mediated actin assembly.
DIAPH3 encodes mDia2, a formin protein that nucleates unbranched actin filaments. It functions downstream of RhoA, Rac1, and Cdc42, and its activation involves RhoA and ROCK. Upon release from autoinhibition, DIAPH3 interacts with profilin?Cactin complexes and actin monomers to accelerate actin polymerization, driving lamellipodia and filopodia formation. DIAPH3 also binds APC at microtubule plus-ends, coordinating actin and microtubule dynamics. Knockout of DIAPH3 in HeLa cells disrupts F-actin assembly, impairs cytoskeletal remodeling, and reduces cell motility. This results in diminished lamellipodial protrusion and filopodial extension.
In the context of HeLa cells, DIAPH3 loss impairs the actin machinery required for efficient migration and invasion, directly mirroring behavior observed in metastatic cancer cells. The polyclonal knockout approach permits the study of these phenotypes within a genetically diverse population, more closely approximating tumor heterogeneity. Moreover, the model extends to DFNA1 hearing loss research, as DIAPH3 mutations are associated with auditory dysfunction. This polyclonal knockout thus serves as a versatile platform for dissecting DIAPH3-dependent cytoskeletal and disease mechanisms.
These polyclonal knockout cells are ideally suited for wound healing and transwell invasion assays to quantify migration and invasion defects. Phalloidin staining enables direct visualization of F-actin organization, while western blotting confirms altered expression of pathway components. Live-cell imaging offers real-time assessment of cytoskeletal dynamics. Together, these applications establish the DIAPH3 Knockout HeLa Polyclonal Cells as a critical resource for cancer metastasis and cytoskeletal research. For additional information and ordering, please contact Ascent Research.
